Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) |  Total Cites (3years) |
Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PLoS Neglected Tropical Diseases | journal | 2.513 Q1 | 163 | 768 | 1590 | 38387 | 8661 | 1565 | 5.21 | 49.98 |  |
| 2 | Life Sciences | journal | 1.074 Q1 | 191 | 385 | 933 | 17353 | 2738 | 923 | 2.97 | 45.07 | |
| 3 | Marine Drugs | journal | 0.780 | 159 | 340 | 674 | 19323 | 2657 | 674 | 3.24 | 56.83 |  |
| 4 | Bioanalysis | journal | 0.686 Q1 | 70 | 319 | 925 | 12404 | 2117 | 738 | 2.17 | 38.88 |  |
| 5 | Medicinal Chemistry Research | journal | 0.412 Q2 | 59 | 479 | 1298 | 16101 | 2054 | 1297 | 1.58 | 33.61 | |
| 6 | ChemMedChem | journal | 1.110 Q1 | 119 | 320 | 688 | 12177 | 1932 | 668 | 2.76 | 38.05 | |
| 7 | Theranostics | journal | 1.955 Q1 | 158 | 97 | 200 | 6416 | 1627 | 181 | 8.14 | 66.14 |  |
| 8 | Handbook of Experimental Pharmacology | journal | 1.647 Q1 | 110 | 118 | 361 | 13886 | 1463 | 340 | 3.80 | 117.68 |  |
| 9 | Pharmacogenetics and Genomics | journal | 1.343 | 152 | 77 | 302 | 3055 | 1207 | 297 | 3.84 | 39.68 | |
| 10 | American Journal of Pharmaceutical Education | journal | 0.423 Q1 | 78 | 207 | 678 | 3821 | 950 | 573 | 1.32 | 18.46 | |
| 11 | Human Vaccines | journal | 1.110 Q1 | 63 | 0 | 264 | 0 | 736 | 199 | 0.00 | 0.00 | |
| 12 | Patient Preference and Adherence | journal | 0.695 Q1 | 67 | 176 | 284 | 6644 | 657 | 281 | 2.28 | 37.75 |  |
| 13 | Expert Review of Clinical Pharmacology | journal | 0.870 Q1 | 60 | 100 | 218 | 6825 | 535 | 185 | 2.18 | 68.25 | |
| 14 | Drug Metabolism Reviews | journal | 1.633 Q1 | 108 | 30 | 89 | 4924 | 501 | 85 | 5.51 | 164.13 | |
| 15 | Clinical and Translational Science | journal | 0.941 Q1 | 60 | 77 | 249 | 1782 | 399 | 199 | 1.53 | 23.14 | |
| 16 | F1000 Biology Reports | journal | 3.327 Q1 | 32 | 0 | 52 | 0 | 289 | 52 | 4.85 | 0.00 | |
| 17 | Therapeutics and Clinical Risk Management | journal | 0.619 Q1 | 70 | 116 | 112 | 5592 | 222 | 106 | 2.02 | 48.21 | |
| 18 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 27 | 73 | 1290 | 221 | 71 | 2.67 | 47.78 | | |
| 19 | Neuromethods | book series | 0.244 Q2 | 24 | 141 | 562 | 7866 | 208 | 490 | 0.31 | 55.79 | |
| 20 | Molecular and Cellular Toxicology | journal | 0.348 Q2 | 28 | 50 | 150 | 1872 | 177 | 150 | 1.37 | 37.44 | |
| 21 | Drug Metabolism and Personalized Therapy | journal | 0.559 Q1 | 38 | 30 | 90 | 1514 | 165 | 79 | 1.84 | 50.47 | |
| 22 | F1000Research | journal | 0.545 Q1 | 105 | 269 | 197 | 9171 | 147 | 192 | 0.75 | 34.09 | |
| 23 | Therapeutic Innovation and Regulatory Science | journal | 0.157 Q3 | 51 | 100 | 407 | 2003 | 140 | 352 | 0.33 | 20.03 | |
| 24 | Drug Discoveries and Therapeutics | journal | 0.456 Q1 | 31 | 22 | 78 | 9 | 126 | 78 | 1.76 | 0.41 |  |
| 25 | Journal of Applied Biomedicine | journal | 0.247 Q2 | 38 | 35 | 68 | 1696 | 122 | 66 | 1.61 | 48.46 |  |
| 26 | Currents in Pharmacy Teaching and Learning | journal | 0.237 Q2 | 31 | 117 | 185 | 2337 | 88 | 171 | 0.42 | 19.97 | |
| 27 | Journal of Pharmacology and Toxicology (discontinued) | journal | 0.264 Q2 | 22 | 12 | 113 | 416 | 82 | 113 | 0.36 | 34.67 | |
| 28 | Journal of Pharmaceutical Investigation | journal | 0.307 Q2 | 39 | 50 | 95 | 1586 | 79 | 94 | 0.83 | 31.72 |  |
| 29 | Neuropsychopharmacologia Hungarica | journal | 0.282 Q2 | 18 | 23 | 91 | 935 | 74 | 78 | 0.85 | 40.65 |  |
| 30 | Value in Health Regional Issues | journal | 0.193 Q3 | 28 | 70 | 106 | 2150 | 70 | 95 | 0.66 | 30.71 | |
| 31 | Journal of Pharmaceutical Health Services Research | journal | 0.231 Q2 | 19 | 34 | 106 | 1011 | 68 | 95 | 0.68 | 29.74 | |
| 32 | American Journal of Pharmacy Benefits | journal | 0.380 Q2 | 16 | 51 | 160 | 1076 | 66 | 137 | 0.43 | 21.10 | |
| 33 | Journal of Pharmaceutical Policy and Practice | journal | 0.814 Q1 | 32 | 61 | 44 | 475 | 66 | 31 | 1.42 | 7.79 | |
| 34 | Progress in Drug Research | book series | 1.595 Q1 | 46 | 23 | 15 | 2373 | 65 | 13 | 0.00 | 103.17 | |
| 35 | Journal of Negative Results in BioMedicine | journal | 0.303 Q2 | 25 | 18 | 50 | 507 | 56 | 50 | 1.00 | 28.17 | |
| 36 | Antibiotics | journal | 0.365 Q2 | 77 | 41 | 37 | 2586 | 55 | 36 | 1.49 | 63.07 | |
| 37 | Expert Opinion on Orphan Drugs | journal | 0.191 Q3 | 27 | 130 | 100 | 8468 | 52 | 100 | 0.52 | 65.14 | |
| 38 | Jundishapur Journal of Natural Pharmaceutical Products | journal | 0.173 Q3 | 30 | 37 | 76 | 899 | 41 | 70 | 0.51 | 24.30 | |
| 39 | Vitae | journal | 0.193 Q3 | 19 | 82 | 134 | 1172 | 41 | 72 | 0.11 | 14.29 |  |
| 40 | American Journal of Pharmacology and Toxicology (discontinued) | journal | 0.155 Q3 | 24 | 21 | 66 | 775 | 30 | 66 | 0.55 | 36.90 | |
| 41 | Journal of Medical Marketing | journal | 0.216 Q3 | 20 | 29 | 103 | 869 | 30 | 86 | 0.35 | 29.97 | |
| 42 | Journal of Research in Pharmacy | journal | 20 | 25 | 77 | 793 | 27 | 77 | 0.36 | 31.72 |  | |
| 43 | Journal of Pharmacy and Nutrition Sciences (discontinued) | journal | 0.146 Q4 | 14 | 34 | 81 | 964 | 26 | 81 | 0.22 | 28.35 |  |
| 44 | Drug Target Insights | journal | 0.435 Q1 | 16 | 7 | 12 | 311 | 23 | 12 | 2.20 | 44.43 |  |
| 45 | Open Access Journal of Clinical Trials | journal | 0.201 Q3 | 15 | 7 | 42 | 411 | 21 | 38 | 0.53 | 58.71 | |
| 46 | Regulatory Rapporteur | trade journal | 0.195 Q3 | 7 | 74 | 214 | 449 | 21 | 174 | 0.08 | 6.07 | |
| 47 | Pharmaceuticals Policy and Law | journal | 0.128 Q4 | 11 | 21 | 61 | 573 | 18 | 55 | 0.24 | 27.29 | |
| 48 | Botulinum Journal | journal | 0.327 Q2 | 6 | 0 | 21 | 0 | 16 | 19 | 0.50 | 0.00 | |
| 49 | European Pharmaceutical Review | trade journal | 0.112 Q4 | 9 | 54 | 143 | 883 | 16 | 143 | 0.07 | 16.35 | |
| 50 | Milestones in Drug Therapy | book series | 0.146 Q3 | 6 | 1 | 98 | 23 | 15 | 93 | 0.19 | 23.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data